Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 1/1998

01-01-1998 | Original Article

A randomized controlled trial on the prevention of seroma after partial or total mastectomy and axillary lymph node dissection

Authors: Makoto Abe, Takuji Iwase, Toru Takeuchi, Hiroshi Murai, Shigeto Miura

Published in: Breast Cancer | Issue 1/1998

Login to get access
Metadata
Title
A randomized controlled trial on the prevention of seroma after partial or total mastectomy and axillary lymph node dissection
Authors
Makoto Abe
Takuji Iwase
Toru Takeuchi
Hiroshi Murai
Shigeto Miura
Publication date
01-01-1998
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 1/1998
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/BF02967417

Other articles of this Issue 1/1998

Breast Cancer 1/1998 Go to the issue

Review Article

Sentinel lymphadenectomy in breast cancer: An alternative to routine axillary dissection

Original Article

Detection of DNA fragmentation in human breast cancer tissue by an antibody specific to single-stranded DNA

Case Report

Acinic cell adenocarcinoma arising in the breast of a young male: A clinicopathological, immunohistochemical and ultrastructural study

Original Article

The current status of the treatment of ductal carcinoma in situ of japanese women, especially breast conserving operation in relation to the surgical margin and short term outcome

Case Report

A case of mucinous carcinoma of the male breast with unusual ultrasonographic findings mimicking phyllodes tumor

Review Article

The molecular mechanism underlying the acquisition of the antiestrogen-resistant phenotype in breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits